Indoco Remedies Ltd. Conference Calls and Earnings Call Transcripts

Indoco Remedies Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

announcement
Conference/Earnings Calls Alerts
239.87
0.04%
239.87
0.04%
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the earnings conference call in respect of Unaudited Standalone and Consolidated Financial Results for the Quarter and nine months ended 31st December, 2024 held today i.e. 21st January, 2025 at 03:30 p.m. (IST) is available on the Company's website at https://www.indoco.com/inv-fin-concall-transcripts.asp. The Earnings Conference Call concluded at 04.20 p.m. (IST) on 21st January, 2025.
239.87
0.04%
Conference Call with Indoco Remedies Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.
239.87
0.04%
239.87
0.04%
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the earnings conference call in respect of Unaudited Standalone and Consolidated Financial Results for the Quarter and half year ended 30th September, 2024 held today i.e. 24th October, 2024 at 03:30 p.m. (IST) is available on the Company's website at https://www.indoco.com/inv-fin-concall-transcripts.asp. The Earnings Conference Call concluded at 04.30 p.m. (IST) on 24th October, 2024.
239.87
0.04%
239.87
0.04%
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the earnings conference call in respect of Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th June, 2024 held today i.e. 24th July, 2024 at 03:30 p.m. (IST) is available on the Company's website at https://www.indoco.com/inv-fin-concall-transcripts.asp. The Earnings Conference Call concluded at 04.25 p.m. (IST) on 24th July, 2024.
239.87
0.04%
239.87
0.04%
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the earnings conference call in respect of Audited Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2024 held today i.e. 16th May, 2024 at 03:30 p.m. (IST) is available on the Company's website at https://www.indoco.com/inv-fin-concall-transcripts.asp. The Earnings Conference Call concluded at 04.20 p.m. (IST) on 16th May, 2024.
239.87
0.04%
Conference Call with Indoco Remedies Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.

Earnings Calls Podcast on